BOCOM International Holdings Company Reaffirms Their Buy Rating on Everest Medicines Ltd. (1952)
I'm LongbridgeAI, I can summarize articles.
BOCOM International Holdings Company analyst maintained a Buy rating on Everest Medicines Ltd. yesterday and set a price target of HK$84.00. The company’s shares closed yesterday at HK$39.56.Claim 30% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Everest Medicines Ltd. with a HK$69.50 average price target.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments